JMP Securities Sticks to Their Hold Rating for Atlassian (TEAM)
In a report released today, Patrick Walravens from JMP Securities maintained a Hold rating on Atlassian (TEAM – Research Report). The company’s ...
JMP Securities Keeps Their Buy Rating on LPL Financial (LPLA)
JMP Securities analyst Devin Ryan reiterated a Buy rating on LPL Financial (LPLA – Research Report) today and set a price target of $435.00.
Why Pharvaris (PHVS) Is Advancing Today
Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on ...
JMP Securities starts Astria Therapeutics stock at Market Outperform
JMP Securities initiated coverage on Astria Therapeutics (NASDAQ: ATXS), assigning a Market Outperform rating and setting a ...
JMP Securities maintains BioCryst stock with $18 target
JMP Securities reiterated its Market Outperform rating on BioCryst Pharmaceuticals (NASDAQ:BCRX) with a consistent price target of $18.00. The firm's analysis is based on the performance and market ...